The angiotensin converting enzyme D allele is an independent risk factor for early onset coronary artery disease

Clinical Biochemistry

Volumn 43, Issue 15, 2010, Pages 1189-1194

  Vaisi Raygani, Asad ^a,b   Ghaneialvar, Hori ^b   Rahimi, Zohreh ^b,c   Nomani, Hamid ^b   Saidi, Mohmadreza ^b   Bahrehmand, Fariborz ^b   Vaisi Raygani, Aliakbar ^f   Tavilani, Haidar ^d   Pourmotabbed, Tayebeh ^e  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TENNESSEE   (United States)

^f KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin converting enzyme; Coronary artery disease; Diabetes mellitus; Genetic polymorphism; Genetic risk factor; Lipid profile; Vessel stenosis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGE OF ONSET; ALLELES; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DEMOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; IRAN; LIPOPROTEINS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; RISK FACTORS; TRIGLYCERIDES;

EID: 77956731297     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.07.010     Document Type: Article

References (43)

1. Kharrazi H., Vaisi-Raygani A., Sabokroh A.R., Pourmotabbed T. Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran. Clin Biochem 2006, 39:613-616.
2. Vaisi-Raygani A., Rahimi Z., Nomani H., Tavilani H., Pourmotabbed T. The presence of apolipoprotein ε4 and ε2 alleles augments the risk of coronary artery disease in type 2 diabetic patients. Clin Biochem 2007, 40:1150-1156.
3. Vaisi Raygani A., Rahimi Z., Entezami H., Kharrazi H., Bahrhemand F., Tavilani H., et al. Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran. Scand J Clin Lab Invest 2008, 68(2):123-129.
4. Vaisi Raygani A., Rahimi Z., Tavilani H., Pourmotabbed T., et al. Butyrylcholinesterase K variant and the APOE-ε4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients. Molec Bio Rep 2010, 37(4):2083-2091.
5. Vaisi Raygani A., Tavilani H., Zahrai M., Rahimi Z., Sheikh N., Aminian M., et al. Serum butyrylcholinesterase activity and phenotype associations with lipid profile in stroke patients. Clin Biochem 2009, 42:210-214.
6. Nikzamir A., Nakhjavani M., Golmohamadi T., Dibai L. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus. Arch Iranian Med 2008, 11(1):3-9.
7. Hatmi Z.N., Tahvildari S., Gafarzadeh Motlag A., Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. Cardiovasc Disord 2007, 7(32):1-5.
8. Shafiee S.M., Firoozrai M., Salimi S., Zand H., Hesabi B., Mohebbi A. Angiotensin converting enzyme DD genotype not associated with increased risk of coronary artery disease in the Iranian population. Pathophysiology 2010, 17(3):163-167.
9. Imazio M., Bobbio M., Bergerone S., Barlera S., Maggioni A.P. Clinical and epidemiological characteristics of juvenile myocardial infarction in Italy: the GISSI experience. G Ital Cardiol 1998, 28(5):505-512.
10. Egred M., Viswanathan G., Davis G.K. Myocardial infarction in young adults. Postgrad Med J 2005, 81(962):741-745.
11. Haidari M., Moghadam M., Chinicar M., Ahmadieh A., Doosti M. Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients. Clin Biochem 2001, 34(2):149-155.
12. Zintzaras E., Raman G., Kitsios G., Lau J. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 2008, 168(10):1077-1089.
13. Sakuma T., Hirata R., Hirata M. Five polymorphisms in genes candidates for cardiovascular disease in afro-Brazilian individuals. J Clin Lab Anal 2004, 18:309-316.
14. Keavney B., McKenzie C., Parish S., Palmer A., Clark S., Youngman L., et al. Large-scale test of hypothesised associations between the angiotensin-converting- enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet 2000, 355:434-442. International Studies of Infarct Survival (ISIS) Collaborators.
15. WHO Study Group Report of a WHO consultation: Part 1. Diagnosis and classification of diabetes mellitus 1999, World Health Organization, Geneva.
16. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel [see comments]. Arch Intern Med 1988, 148:36-69.
17. Johan S.W.M., Weitzner G., Rozen R. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 1991, 19:408.
18. Tiret L., Rigat B., Visvikis S., Breda C., Corovol P., Cambien F., et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin 1 converting enzyme(ACE) gene controls plasma ACE level. Am J Hum Genet 1992, 51:197-205.
19. Sekuri C., Cam F.S., Ercan E., Tengiz I., Sagcan A., Eser E., et al. Renin-angiotensin system gene polymorphisms and premature coronary heart disease. JRAAS 2005, 6:38-42.
20. Ermis C., Tsai M.Y., Hanson N.Q., Akar N., Aras O. Angiotensin I converting enzyme, angiotensin II type I receptor and angiotensinogen polymorphisms and early myocardial infarction in Turkish population. Thromb Haemost 2002, 88:693-694.
21. Alvarez R., Reguero J.R., Batalla A. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res 1998, 40:375-379.
22. Dzimiri N., Basco C., Moorji A., Meyer B.F. Angiotensin-converting enzyme polymorphism and the risk of coronary heart disease in the Saudi male population. Arch Pathol Lab Med 2000, 124(4):531-534.
23. Hoshida S., Kato J., Nishino M., Egami Y., Takeda T., Kawabata M., et al. Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome. Circulation 2001, 103(5):630-633.
24. Van Bockxmeer F.M., Mamotte C.D.S., Burke V., Taylor R.R. Angiotensin converting enzyme gene polymorphism and pre-mature coronary heart disease. Clin Sci 2000, 99:247-251.
25. Mannami T., Katsuya T., Baba S., Inamoto N., Ishikawa K., Higaki J., et al. Low potentiality of angiotensin-converting enzyme gene insertion/deletion polymorphism as a useful predictive marker for carotid atherogenesis in a large general population of a Japanese city: the Suita study. Stroke 2001, 32:1250-1256.
26. Feng Y., Niu T., Xu X., Chen C., Li Q., Qian R. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 2002, 51:1986-1988.
27. Igic R., Behnia R. Properties and distribution of angiotensin I converting enzyme. Curr Pharm Des 2003, 9(9):697-706.
28. Cambien F., Poirier O., Lecerf L., Evans A., Cambou JP., Arveiler D., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
29. Tiret L., Bonnardeaux A., Poirier Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor DD genotype of the gene polymorphisms on risk of myocardial infarction. Lancet 1994, 344:910-913.
30. Jeunemaitre X., Ledru F., Battaglia S. Genetic polymorphisms of the reninangiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet 1997, 99:66-73.
31. Santovito A., Bulgarello C., Cervella P., Bigatti M.P., Delpero M. Allelic frequencies at the ACE and LRPAP1 loci suggest age-related relationships in a northern Italian population. Ann Hum Biol 2007, 34(1):102-106.
32. Franco E., Palumbo L., Crobu F., Anselmino M., Frea S., Matullo G., et al. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med Genet 2007, 22(8):27.
33. Yang Q., Khoury M.J. Evolving methods in genetic epidemiology III. Gene-environment interaction in epidemiologic research. Epidemiol Rev 1997, 19:33-43.
34. Freitas A.I., Mendonça I., Brión M., Sequeira M.M., Reis R.P., Carracedo A., et al. RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population. Cardiovasc Disord 2008, 17(8):15-20.
35. Poirier O., Georges J.L., Ricard S., Arveiler D., Ruidavets J.B., Luc G., et al. New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Hypertens 1998, 16(10):1443-1447.
36. Samani N.J., Thompson J.R., O'Toole L., Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996, 94:708-712.
37. Keavney B., McKenzie C., Parish S., Palmer A., Clark S., Youngman L., et al. Large-scale test of hypothesized associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet 2000, 355:434-442.
38. Tiret L., Bonnardeaux A., Poirier O., Ricard S., Marques-Vidal P., Evans A., et al. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994, 344:910-913.
39. Rodríguez-Pérez J.C., Rodríguez-Esparragón F., Hernández-Perera O., Anabitarte A., Losada A., Medina A., et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. J Am Coll Cardiol 2001, 37(6):1536-1542.
40. Kretowski A., McFann K., Hokanson J.E., Maahs D., Kinney G., Snell-Bergeon J.K., et al. Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes 2007, 56:863-871.
41. Tsai C.T., Hwang J.J., Ritchie M.D., Moore J.H., Chiang F.T., Lai L.P., et al. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 2007, 195(1):172-180.
42. Tamaki S., Nakamura Y., Tsujita Y., Nozaki A., Amamoto K., Kadowaki T., et al. Polymorphism of the angiotensin converting enzyme gene and blood pressure in a Japanese general population (the Shigaraki Study). Hypertens Res 2002, 25(6):843-848.
43. Seckin D., Ilhan N., Ilhan N., Ozbay Y. The relationship between ACE insertion /deletion polymorphism and coronary artery disease with or without myocardial infarction. Clin Biochem 2006, 39:50-54.